Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1077183/000107718320000108/neo-20200429.htm
April 2024
February 2024
February 2024
November 2023
August 2023
June 2023
May 2023
May 2023
May 2023
April 2023
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1077183/000107718320000108/neo-20200429.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Neogenomics Inc.
Neogenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Neogenomics Inc provided additional information to their SEC Filing as exhibits
Ticker: NEOEvents:
CIK: 1077183
Form Type: 8-K Corporate News
Accession Number: 0001077183-20-000108
Submitted to the SEC: Mon May 04 2020 5:18:56 PM EST
Accepted by the SEC: Mon May 04 2020
Period: Wednesday, April 29, 2020
Industry: Testing Laboratories